Kalamazoo, MI-based Metabolic Solutions Development has raised more than $9 million from private investors and $1.3 million from the NIH to fund development of a new diabetes therapy. "It's nice to have a strong market, but if we can keep producing data, there is cash out there. It's just tougher to get," CEO Mark Olesnavage said. "But for good-quality investments, people are looking for that, so you'd better have a compelling story." Report